对于患有急性髓性白血病的老年人,持续寻找有效的治疗方法
1Hospices Civils de Lyon, Department of Clinical Hematology, Centre Hospitalier Lyon-Sud, Pierre Bénite, France.
Expert review of clinical pharmacology
|November 26, 2025
概括
对于患有急性髓性白血病 (AML) 的老年人来说,治疗现在专注于长期生存. 威尼托克拉克斯与低甲基化剂 (HMA) 的组合是一种新的标准,推动了对新型组合疗法的研究.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 对于患有急性髓性白血病 (AML) 的老年人 (≥60岁) 的治疗目标已经转向通过延长疗法实现长期生存.
- 新型治疗药物已获得批准,并正在研究用于AML治疗的组合疗法.
研究的目的:
- 审查老年AML患者的新兴治疗策略,重点关注向组合疗法.
- 在这个患者群体中识别和评估新型治疗剂的疗效和安全性.
主要方法:
- 在主要的科学数据库 (PubMed,ASH,EHA) 和临床试验注册表中进行了全面的文献搜索.
- 搜索的重点是确定详细介绍新兴治疗剂和老年AML组合疗法的有效性和安全性的研究.
主要成果:
- 老年AML患者的治疗环境已经向基于分子亚型的个性化药物发展.
- 威尼托克拉克斯与低甲基化剂 (HMA) 的组合已成为新的护理标准,显示出良好的结果.
- 这种协同作用的组合为新研究铺平了道路,将其他向药物添加到脊柱治疗方案中.
结论:
- 个性化,有针对性的疗法正在改变老年人的AML治疗.
- 维内托克拉克斯/HMA组合代表了重大进展,为研究开辟了新的途径,改善了患者的治疗结果.
- 未来的研究很可能会专注于优化组合疗法,以进一步提高这一人口群的长期生存率.
相关概念视频
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Bone Marrow Sampling and Transplants
845
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
845
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Stem Cell Therapy for Tissue Regeneration
4.6K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.6K
Alzheimer's Disease: Treatment
772
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
772


